Unilever-McCormick $44.8 Billion Deal Faces UK Antitrust Scrutiny

The UK's CMA raised concerns about Unilever and McCormick's $44.8B deal, citing potential competition issues in dry cooking mixes and sauces. The companies must address these by Nov. 18 or face further investigation. Unilever is divesting its Colman’s brand to mitigate concerns. The deal is central to Unilever's restructuring strategy, with McCormick paying $15.7B in cash and Unilever shareholders receiving 65% ownership in the combined company.

Original reporting
Published Nov 11, 2026, 4:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 5:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Unilever-McCormick $44.8 Billion Deal Faces UK Antitrust Scrutiny — source image
Decision brief

The 30-second read

$ULBearishHigh
01

Why it matters

Regulatory delay could compress Unilever’s valuation multiple, while a cleared deal would enhance earnings visibility for the combined entity.

02

Market read

The antitrust review adds a near‑term risk to a multi‑billion‑dollar M&A, likely influencing both stocks and the broader consumer‑goods sector.

03

What to watch

Potential benefits from combined supply chains and cost savings may outweigh short‑term regulatory risk, especially if Unilever accelerates its beauty‑care focus.

Relevance 9/10Novelty 9/10Timing: before Nov 18 deadline for CMA remedial proposals

Background

Unilever aims to spin off its food business to focus on higher‑growth beauty and personal‑care segments; the UK CMA’s review targets competition in dry mixes and sauces.

Company-level read

Ticker impact

$ULBearishHigh confidence
Context

UK CMA opened a preliminary antitrust review of Unilever's $44.8 bn acquisition of McCormick, creating regulatory uncertainty.

Expected impact

likely downward pressure on Unilever as investors price in possible concessions or deal risk; McCormick may see modest upside if the deal is renegotiated favorably.

Evidence & confidence

The CMA has set a Nov 18 deadline for remedial proposals; such antitrust reviews historically cause short‑term sell‑offs for target acquirers.

$MKCBearishHigh confidence
Context

McCormick is the target in the $44.8 bn Unilever food‑business acquisition now facing UK antitrust review.

Expected impact

moderate pressure as the market awaits CMA outcome; potential upside if the merger clears with minimal divestitures.

Evidence & confidence

McCormick’s share price is tied to the transaction’s completion; regulatory hurdles introduce risk but also a possible catalyst if cleared.

Market effects

Food‑ingredients and consumer‑goods sector may see heightened scrutiny on future consolidations in the UK.

UK consumer‑goods stocks could experience broader pressure as regulators signal tougher antitrust stance.

The deal’s size makes it a headline M&A story worldwide, influencing global M&A sentiment.

Counterpoint

The CMA review could be a formality; Unilever may secure approvals with limited divestitures, allowing the deal to proceed and unlock synergies.

Key entities

  • Unilever

    Global consumer‑goods group seeking to divest its food division.

  • McCormick

    Spice and seasoning maker acquiring Unilever’s food assets.

  • UK Competition and Markets Authority (CMA)

    UK antitrust authority reviewing the transaction.

Related articles

$ULMed

McCormick facing probe into $65 billion food deal

The UK's Competition and Markets Authority (CMA) has raised concerns about Unilever's $65 billion food deal with McCormick, citing potential competition issues in recipe mixes and sauces. The companies must address these concerns by November 18 to avoid an in-depth investigation. Unilever and McCormick are working with the CMA to find a suitable remedy. The deal aims to create a company worth around $65 billion, combining Unilever's food business with McCormick's spice and sauce products.

$ULHigh

Deutsche Bank Resets Unilever Stock Target Amid Market Turmoil

Deutsche Bank upgraded Unilever (UL) to Buy, raising its price target to 5,350 pence. The bank cites Unilever's defensive qualities, growth prospects, and operational improvements. Unilever reported 5.2% underlying sales growth in Q3 and aims for 1 billion in savings by 2029. Deutsche Bank forecasts 4.6% and 4.2% growth for 2027 and 2028, respectively, with margin improvements. The bank sees potential upside of 8.5% from current London share prices.

$ULMedAI 8/10

UK Regulator Gives Unilever and McCormick Until Nov. 18 to Fix Competition Concerns or Face Deeper Probe into $65 Billion Food Merger — BigGo Finance

UK's CMA gave Unilever (UL) and McCormick (MKC) until Nov. 18 to address competition concerns over their $65B food merger or face a deeper probe. The regulator found the deal could reduce competition in dry ingredient mixes and sauces. Both companies are cooperating. McCormick shares fell 2.1% in London trading. The merger, expected to close mid-2027, would create a $65B company with $600M in annual cost synergies.

$MKCHigh

McCormick Stock (MKC) Slides as U.K. Watchdog Threatens Probe into $65B Unilever (UL) Food Merger

McCormick (MKC) and Unilever (UL) shares fell as the UK's CMA threatened a probe into their $65B merger. The CMA raised concerns about reduced competition in dry ingredient mixes and sauces. Both companies must address these concerns by November 18. The deal, valued at $65B, aims to create a major food company, with Unilever shareholders owning 55.1% and McCormick shareholders 35%. McCormick's CEO will lead the combined entity.

$ULMedAI 9/10

McCormick and Unilever’s $45B food merger hits antitrust snag in UK

McCormick & Co. and Unilever's $44.8B food merger faces a potential in-depth UK investigation. The Competition and Markets Authority (CMA) expressed concerns about reduced competition in dry ingredients and sauces. The companies have until Nov. 18 to address the CMA's concerns. McCormick and Unilever are working on remedies, including Unilever's sale of the Colman's brand.